Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Sci. Signal., 26 May 2009
Vol. 2, Issue 72, p. re3
[DOI: 10.1126/scisignal.272re3]
REVIEWS
CD36, a Scavenger Receptor Involved in Immunity, Metabolism, Angiogenesis, and Behavior
Roy L. Silverstein* and
Maria Febbraio
Department of Cell Biology, Lerner Research Institute, Cleveland Clinic Foundation and Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH 44195, USA.
Abstract:
CD36 is a membrane glycoprotein present on platelets, mononuclear phagocytes, adipocytes, hepatocytes, myocytes, and some epithelia. On microvascular endothelial cells, CD36 is a receptor for thrombospondin-1 and related proteins and functions as a negative regulator of angiogenesis. On phagocytes, through its functions as a scavenger receptor recognizing specific oxidized phospholipids and lipoproteins, CD36 participates in internalization of apoptotic cells, certain bacterial and fungal pathogens, and modified low-density lipoproteins, thus contributing to inflammatory responses and atherothrombotic diseases. CD36 also binds long-chain fatty acids and facilitates their transport into cells, thus participating in muscle lipid utilization, adipose energy storage, and gut fat absorption and possibly contributing to the pathogenesis of metabolic disorders, such as diabetes and obesity. On sensory cells, CD36 is involved in insect pheromone signaling and rodent fatty food preference. The signaling pathways downstream of CD36 involve ligand-dependent recruitment and activation of nonreceptor tyrosine kinases, specific mitogen-activated protein kinases, and the Vav family of guanine nucleotide exchange factors; modulation of focal adhesion constituents; and generation of intracellular reactive oxygen species. CD36 in many cells is localized in specialized cholesterol-rich membrane microdomains and may also interact with other membrane receptors, such as tetraspanins and integrins. Identification of the precise CD36 signaling pathways in specific cells elicited in response to specific ligands may yield novel targets for drug development.
Citation: R. L. Silverstein, M. Febbraio, CD36, a Scavenger Receptor Involved in Immunity, Metabolism, Angiogenesis, and Behavior. Sci. Signal.2, re3 (2009).
The editors suggest the following Related Resources on Science sites:
In Science Signaling
EDITORS' CHOICE
Nancy R. Gough (23 August 2011) Sci. Signal.4 (187), ec235.
[DOI: 10.1126/scisignal.4187ec235] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Reduced CD36-dependent tissue sequestration of Plasmodium-infected erythrocytes is detrimental to malaria parasite growth in vivo.
J. Fonager, E. M. Pasini, J. A. M. Braks, O. Klop, J. Ramesar, E. J. Remarque, I. O. C. M. Vroegrijk, S. G. van Duinen, A. W. Thomas, S. M. Khan, et al. (2012)
J. Exp. Med.
209, 93-107
|Abstract »|Full Text »|PDF »
Gene Expression in Livers of BALB/C and C57BL/6J Mice Fed a High-Fat Diet.
S. Nishikawa, J. Sugimoto, M. Okada, T. Sakairi, and S. Takagi (2012)
Toxicol Pathol
40, 71-82
|Abstract »|Full Text »|PDF »
Clinical significance of serum levels of sCD36 in patients with systemic sclerosis: preliminary data.
I. H. Bassyouni, T. A. Gheita, and R. M. Talaat (2011)
Rheumatology
50, 2108-2112
|Abstract »|Full Text »|PDF »
Luminal Lipid Regulates CD36 Levels and Downstream Signaling to Stimulate Chylomicron Synthesis.
T. T. T. Tran, H. Poirier, L. Clement, F. Nassir, M. M. A. L. Pelsers, V. Petit, P. Degrace, M.-C. Monnot, J. F. C. Glatz, N. A. Abumrad, et al. (2011)
J. Biol. Chem.
286, 25201-25210
|Abstract »|Full Text »|PDF »
Platelet CD36 surface expression levels affect functional responses to oxidized LDL and are associated with inheritance of specific genetic polymorphisms.
A. Ghosh, G. Murugesan, K. Chen, L. Zhang, Q. Wang, M. Febbraio, R. M. Anselmo, K. Marchant, J. Barnard, and R. L. Silverstein (2011)
Blood
117, 6355-6366
|Abstract »|Full Text »|PDF »
Lysophosphatidic acid suppresses endothelial cell CD36 expression and promotes angiogenesis via a PKD-1-dependent signaling pathway.
B. Ren, J. Hale, S. Srikanthan, and R. L. Silverstein (2011)
Blood
117, 6036-6045
|Abstract »|Full Text »|PDF »
CD36 Protein Is Involved in Store-operated Calcium Flux, Phospholipase A2 Activation, and Production of Prostaglandin E2.
O. Kuda, C. M. Jenkins, J. R. Skinner, S. H. Moon, X. Su, R. W. Gross, and N. A. Abumrad (2011)
J. Biol. Chem.
286, 17785-17795
|Abstract »|Full Text »|PDF »
Hematopoietic Cell-Restricted Deletion of CD36 Reduces High-Fat Diet-Induced Macrophage Infiltration and Improves Insulin Signaling in Adipose Tissue.
H. T. Nicholls, G. Kowalski, D. J. Kennedy, S. Risis, L. A. Zaffino, N. Watson, P. Kanellakis, M. J. Watt, A. Bobik, A. Bonen, et al. (2011)
Diabetes
60, 1100-1110
|Abstract »|Full Text »|PDF »
S. O. Rahaman, W. Swat, M. Febbraio, and R. L. Silverstein (2011)
J. Biol. Chem.
286, 7010-7017
|Abstract »|Full Text »|PDF »
αM{beta}2 Integrin Activation Prevents Alternative Activation of Human and Murine Macrophages and Impedes Foam Cell Formation.
V. P. Yakubenko, A. Bhattacharjee, E. Pluskota, and M. K. Cathcart (2011)
Circ. Res.
108, 544-554
|Abstract »|Full Text »|PDF »
Polymorphisms in the CD36/FAT gene are associated with plasma vitamin E concentrations in humans.
S. Lecompte, F. Szabo de Edelenyi, L. Goumidi, G. Maiani, G. Moschonis, K. Widhalm, D. Molnar, A. Kafatos, A. Spinneker, C. Breidenassel, et al. (2011)
Am J Clin Nutr
93, 644-651
|Abstract »|Full Text »|PDF »
CD36: the common soil for inflammation in obesity and atherosclerosis?.
Z. Yang and X.-F. Ming (2011)
Cardiovasc Res
89, 485-486
|Full Text »|PDF »
Brain angiogenesis inhibitor 1 (BAI1) is a pattern recognition receptor that mediates macrophage binding and engulfment of Gram-negative bacteria.
S. Das, K. A. Owen, K. T. Ly, D. Park, S. G. Black, J. M. Wilson, C. D. Sifri, K. S. Ravichandran, P. B. Ernst, and J. E. Casanova (2011)
PNAS
108, 2136-2141
|Abstract »|Full Text »|PDF »
Common CD36 SNPs reduce protein expression and may contribute to a protective atherogenic profile.
L. Love-Gregory, R. Sherva, T. Schappe, J.-S. Qi, J. McCrea, S. Klein, M. A. Connelly, and N. A. Abumrad (2011)
Hum. Mol. Genet.
20, 193-201
|Abstract »|Full Text »|PDF »
Nuclear Orphan Receptor TAK1/TR4-Deficient Mice Are Protected Against Obesity-Linked Inflammation, Hepatic Steatosis, and Insulin Resistance.
H. S. Kang, K. Okamoto, Y.-S. Kim, Y. Takeda, C. D. Bortner, H. Dang, T. Wada, W. Xie, X.-P. Yang, G. Liao, et al. (2011)
Diabetes
60, 177-188
|Abstract »|Full Text »|PDF »
The Evolution of Extracellular Matrix.
S. Ozbek, P. G. Balasubramanian, R. Chiquet-Ehrismann, R. P. Tucker, and J. C. Adams (2010)
Mol. Biol. Cell
21, 4300-4305
|Abstract »|Full Text »|PDF »
Oxidized Low-Density Lipoprotein and Atherosclerosis.
D. Steinberg and J. L. Witztum (2010)
Arterioscler Thromb Vasc Biol
30, 2311-2316
|Full Text »|PDF »
Regulation of Platelet Function by Class B Scavenger Receptors in Hyperlipidemia.
A. Zimman and E. A. Podrez (2010)
Arterioscler Thromb Vasc Biol
30, 2350-2356
|Abstract »|Full Text »|PDF »
Tlr2 is critical for diet-induced metabolic syndrome in a murine model.
Disease-causing mutations within the lysosomal integral membrane protein type 2 (LIMP-2) reveal the nature of binding to its ligand {beta}-glucocerebrosidase.
J. Blanz, J. Groth, C. Zachos, C. Wehling, P. Saftig, and M. Schwake (2010)
Hum. Mol. Genet.
19, 563-572
|Abstract »|Full Text »|PDF »
